Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

1.1K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.1K
Birth Control Methods01:22

Birth Control Methods

5.9K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contraception Among Women with Selected Autoimmune Diseases in the United States, 2019: A Claims Analysis.

Journal of women's health (2002)·2026
Same author

Online patient education in breast reconstruction: A systematic review and meta-analysis of readability, quality, usability, and cultural representation.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2026
Same author

Socio-behavioral factors linked to willingness to use new male contraceptives: A cross-sectional survey of men and female partners across four low- and middle-income countries.

Contraception·2026
Same author

PLX5622 did not alter anxiety-like behaviour and showed limited microglial depletion efficacy in a spinal cord injury model in female rats.

Scientific reports·2026
Same author

Examining the association between prior medical mistreatment and interest in and support for over-the-counter medication abortion among people seeking in-person abortion in the United States.

BMC health services research·2026
Same author

Accuracy of Self-Selection for Medication Abortion Using a Prototype Drug Facts Label.

JAMA internal medicine·2026

Related Experiment Video

Updated: Jan 17, 2026

Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

3.5K

Misoprostol for intrauterine device placement.

Lauren B Zapata1, Emily Snyder1,2, Antoinette T Nguyen1

  • 1Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

The Cochrane Database of Systematic Reviews
|September 23, 2025
PubMed
Summary

Misoprostol does not significantly reduce pain or improve ease of intrauterine device (IUD) placement for most women. However, it may slightly increase placement success for those with a recent failed attempt but also increases side effects like cramping and diarrhea.

More Related Videos

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
06:49

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model

Published on: April 7, 2023

2.2K
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

1.1K

Related Experiment Videos

Last Updated: Jan 17, 2026

Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

3.5K
Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
06:49

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model

Published on: April 7, 2023

2.2K
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

1.1K

Area of Science:

  • Reproductive Health
  • Gynecology
  • Clinical Trials

Background:

  • Intrauterine device (IUD) placement can be associated with pain and technical challenges for providers.
  • Misoprostol is investigated for its potential to soften the cervix, easing IUD insertion and reducing pain.

Purpose of the Study:

  • To evaluate the efficacy of misoprostol in improving patient and provider outcomes during routine IUD placement compared to placebo or no treatment.

Main Methods:

  • Systematic review and meta-analysis of 14 randomized controlled trials (RCTs) involving 1972 women undergoing interval IUD placement.
  • Outcomes assessed included pain, ease of placement, cervical dilation, success rates, patient satisfaction, and adverse events.
  • GRADE methodology was used to assess the certainty of evidence.

Main Results:

  • Misoprostol showed little to no difference in pain during tenaculum placement and after IUD insertion (high-certainty evidence).
  • It had little to no effect on providers' ease of placement, need for cervical dilation, or overall placement success, except for a probable increase in success for women with a recent failed IUD attempt.
  • Misoprostol use was associated with a probable increase in preplacement abdominal pain/cramping and diarrhea, with very uncertain evidence for increased patient satisfaction.

Conclusions:

  • For routine IUD placement, misoprostol offers minimal benefits regarding pain reduction or improved provider ease, with probable increases in side effects.
  • A potential benefit for placement success exists for women with a recent failed IUD attempt, but this must be weighed against increased adverse effects.
  • Further research is needed to explore effect modifiers, as current evidence is limited.